Everhart Financial Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Everhart Financial Group, Inc.
- $340 Million
- Q1 2024
A detailed history of Everhart Financial Group, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 1,378 shares of MDGL stock, worth $403,698. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,378
Previous 1,143
20.56%
Holding current value
$403,698
Previous $264,000
39.02%
% of portfolio
0.11%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
315Shares Held
20MCall Options Held
824KPut Options Held
1.04M-
Janus Henderson Group PLC London, X02.6MShares$762 Million0.39% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$577 Million6.66% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.94MShares$570 Million6.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.78MShares$520 Million34.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$489 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.01B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...